Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT).
Nakamura M, Muramatsu T, Yokoi H, Okada H, Ochiai M, Suwa S, Hozawa H, Kawai K, Awata M, Mukawa H, Fujita H, Shiode N, Asano R, Tsukamoto Y, Yamada T, Yasumura Y, Ohira H, Miyamoto A, Takashima H, Ogawa T, Matsuyama Y, Nanto S; J-DESsERT investigators.
Nakamura M, et al. Among authors: awata m.
Cardiovasc Interv Ther. 2015 Apr;30(2):103-14. doi: 10.1007/s12928-014-0279-z. Epub 2014 Jun 27.
Cardiovasc Interv Ther. 2015.
PMID: 24969222
Clinical Trial.